Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
2,215,257
-
Share change
-
+184
-
Total reported value
-
$357,839,814
-
Price per share
-
$161.69
-
Number of holders
-
103
-
Value change
-
+$3,571,560
-
Number of buys
-
37
-
Number of sells
-
53
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q4 2015
As of 31 Dec 2015,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,215,257 shares.
The largest 10 holders included
MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, LPL Financial LLC, WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, ARS Wealth Advisors, LLC, BROWN ADVISORY INC, SPC Financial, Inc., and UBS Group AG.
This page lists
103
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.